| Dr Elleni Woldesenbet, MD | |
|
3132 Matlock Rd, Suite #309, Arlington, TX 76015-2910 | |
| (817) 417-0260 | |
| (817) 417-4834 |
| Full Name | Dr Elleni Woldesenbet |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 33 Years |
| Location | 3132 Matlock Rd, Arlington, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861459869 | NPI | - | NPPES |
| 8R0520 | Other | TX | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | L0707 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Arlington Memorial Hospital | Arlington, TX | Hospital |
| Entity Name | Arlington Infectious Disease Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083803787 PECOS PAC ID: 4183681737 Enrollment ID: O20041215000181 |
News Archive
An imaging study by Massachusetts General Hospital investigators has identified differences in key brain structures of individuals whose physical or mental health has been most seriously impaired by a common but poorly understood condition called functional neurological disorder (FND).
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.
Scientists are harnessing hard X-rays in the fight against cancer. A team of researchers, in conjunction with the U.S. Department of Energy's (DOE) Argonne National Laboratory, has used ultrabright X-ray light to determine how specific types of antibodies can tell the difference between different forms of a cancer-linked molecule.
Researchers from North Carolina State University, Sandia National Laboratories, and the University of California, San Diego have developed new technology that uses microneedles to allow doctors to detect real-time chemical changes in the body - and to continuously do so for an extended period of time.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elleni Woldesenbet, MD 2718 Shadow Wood Dr, Arlington, TX 76006-2724 Ph: (817) 608-0625 | Dr Elleni Woldesenbet, MD 3132 Matlock Rd, Suite #309, Arlington, TX 76015-2910 Ph: (817) 417-0260 |
News Archive
An imaging study by Massachusetts General Hospital investigators has identified differences in key brain structures of individuals whose physical or mental health has been most seriously impaired by a common but poorly understood condition called functional neurological disorder (FND).
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.
Scientists are harnessing hard X-rays in the fight against cancer. A team of researchers, in conjunction with the U.S. Department of Energy's (DOE) Argonne National Laboratory, has used ultrabright X-ray light to determine how specific types of antibodies can tell the difference between different forms of a cancer-linked molecule.
Researchers from North Carolina State University, Sandia National Laboratories, and the University of California, San Diego have developed new technology that uses microneedles to allow doctors to detect real-time chemical changes in the body - and to continuously do so for an extended period of time.
› Verified 6 days ago
Dr. Waldo P Bracy Jr., M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 N Waldrop Dr, Ste. 509, Arlington, TX 76012 Phone: 817-394-4300 Fax: 817-394-0200 | |
Thang D Le, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 800 W Randol Mill Rd Ste 2300, Arlington, TX 76012 Phone: 866-202-1032 Fax: 817-548-6649 | |
Dr. Hujefa Yusuf Vora, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3150 Matlock Rd, Suite 403, Arlington, TX 76015 Phone: 817-784-0052 Fax: 817-375-5800 | |
Dr. Raza Askari, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd Ste 210, Arlington, TX 76014 Phone: 817-375-5847 | |
Thuc Quyen Thi Nguyen, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd, Suite 210, Arlington, TX 76014 Phone: 817-417-4027 Fax: 817-417-4043 | |
Dr. Bienvenido Gatmaitan Gatmaitan, Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 621 Matlock Centre Cir, Arlington, TX 76015 Phone: 817-860-6062 Fax: 817-795-6652 | |
Bernard A Mcgowen, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1217 Florida Dr, Suite 121, Arlington, TX 76015 Phone: 817-419-9155 Fax: 817-419-9412 |